Collectively, this study demonstrates that APG-115 activates p53 and thus inhibits multiple pro-survival mechanisms, which provides a rational explanation for APG-115 efficiency in inducing cell apoptosis in CLL. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.